Skip to main content

Ayala Pharmaceuticals, Inc.

ADXSDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001100397

Ayala Pharmaceuticals, Inc. was delisted in 2025; its insiders filed their last Form 4 on Mar 6, 2024; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.

Q1 2024 vs. Q4 2023

How the institutions holding Ayala Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of ADXS: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders01+1
Shares03+3
Value$0$2+$2

New holders (1)

Institutions that held Ayala Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to ADXS in Q1 2024
InstitutionSharesValue% of portfolio
Vermillion & White Wealth Management Group, LLC3$20.00%

Sold out (0)

Institutions that held Ayala Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

None.